{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:19:28Z","timestamp":1791335968737,"version":"4.3.1"},"reference-count":66,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["OncoImmunology"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/2162402x.2025.2611458","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T08:55:52Z","timestamp":1768985752000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["Killing cancer takes guts: lessons learned from the manipulation of gut microbiome and immunotherapy for the future of urothelial carcinoma"],"prefix":"10.1080","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4945-3396","authenticated-orcid":false,"given":"Nihaal","family":"Reddy","sequence":"first","affiliation":[{"name":"Department of Medicine, University of California","place":["San Diego, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kire","family":"Lau","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California","place":["San Diego, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Naman","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California","place":["San Diego, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California","place":["San Diego, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"McGillivary","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology-Oncology, University of California","place":["San Diego, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirali","family":"Salmasi","sequence":"additional","affiliation":[{"name":"Department of Urology, University of California","place":["San Diego, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Liss","sequence":"additional","affiliation":[{"name":"Department of Urology, University of California","place":["San Diego, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler","family":"Stewart","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology-Oncology, University of California","place":["San Diego, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013774.pub2"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.21037\/apm-22-1350"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2017.10.041"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11934-018-0851-7"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.5306\/wjco.v8.i1.37"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.21037\/hbsn.2018.10.02"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.3390\/nu13072217"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2018.1527167"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.21037\/tcr.2018.05.37"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.21037\/hbsn.2018.11.12"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro.2018.12"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2018.12"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0285-2"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2017.286229"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2017.182"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.03.060"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan3706"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan4236"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-13234-1"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc9113"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2025.07.012"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.116172"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aac4255"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2024.2374954"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1159\/000282409"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1159\/000475138"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2007.09.031"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/cas.15666"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1159\/000058450"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31959"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2023.12.014"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature14139"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.01706"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05762-y"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-018-0636-7"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2018.08.011"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad1329"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2005.05.007"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2023-329515"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb5920"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf3363"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02453-x"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01694-6"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-024-01923-9"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx108"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10391"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01406-6"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-SITC2024.0669"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.08.2320"},{"key":"e_1_3_4_51_1","unstructured":"Phase II trial of fecal microbial transplantation in patients with advanced non-small cell lung cancer and melanoma treated with immune checkpoint inhibitors. Montreal: US National Library of Medicine. https:\/\/clinicaltrials.gov\/study\/NCT04951583."},{"key":"e_1_3_4_52_1","unstructured":"Microbiota transplant in advanced lung cancer treated with immunotherapy. Madrid: US National Library of Medicine. https:\/\/clinicaltrials.gov\/study\/NCT04924374."},{"key":"e_1_3_4_53_1","unstructured":"Fecal microbiota transplantation to improve efficacy of immune checkpoint inhibitors in metastatic lung cancer. Be'er Sheva Israel: US National Library of Medicine. https:\/\/clinicaltrials.gov\/study\/NCT05502913."},{"key":"e_1_3_4_54_1","unstructured":"A phase II single arm study of fecal microbiota transplant (FMT) in men with metastatic castration resistant prostate cancer whose cancer has not responded to enzalutamide + pembrolizumab. Portland: US National Library of Medicine. https:\/\/clinicaltrials.gov\/study\/NCT04116775."},{"key":"e_1_3_4_55_1","unstructured":"Investigator-initiated trial of fecal microbiota transplant (FMT) capsule for improving the efficacy of anti-PD-1 in patients with PD-(L)1 resistant digestive system cancers. Peking: US National Library of Medicine. https:\/\/clinicaltrials.gov\/study\/NCT04130763."},{"key":"e_1_3_4_56_1","unstructured":"Pilot trial of fecal microbiota transplantation and re-introduction of anti-PD-1 therapy in dMMR colorectal adenocarcinoma anti-PD-1 non-responders. Houston (MD Anderson): US National Library of Medicine. https:\/\/clinicaltrials.gov\/study\/NCT04729322."},{"key":"e_1_3_4_57_1","unstructured":"Pilot study using fecal microbial transplants in patients with pancreatic cancer. Houston (MD Anderson): US National Library of Medicine. https:\/\/clinicaltrials.gov\/study\/NCT04975217."},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2022.40.16_suppl.4553"},{"key":"e_1_3_4_59_1","unstructured":"An open label randomized control study of probiotics administration in the immunotherapy of urothelial bladder carcinoma. Tianjin: US National Library of Medicine. https:\/\/clinicaltrials.gov\/study\/NCT05220124."},{"key":"e_1_3_4_60_1","unstructured":"Predictive role of microbiome in patients with urothelial carcinoma. Milan: US National Library of Medicine. https:\/\/clinicaltrials.gov\/study\/NCT06675656."},{"key":"e_1_3_4_61_1","unstructured":"Analysis of the evolution of proteomic profiles of intestinal microbiota in patients with locally advanced or metastatic urothelial carcinomas according to their response to immunotherapy (responders vs. non-responders: a prospective pilot study. Nimes: National Library of Medicine (US). https:\/\/clinicaltrials.gov\/study\/NCT04566029."},{"key":"e_1_3_4_62_1","unstructured":"A phase I\/Ib study to evaluate the safety tolerability biological and clinical activities of GEN-001 in combination with avelumab in patients with advanced solid tumors who have progressed during or after treatment with anti-PD-(L)1 therapy. New Haven: US National Library of Medicine. https:\/\/clinicaltrials.gov\/study\/NCT04601402."},{"key":"e_1_3_4_63_1","unstructured":"A multicenter randomized controlled phase II study of evaluating the efficacy and safety of immunotherapy combined with oral probiotics compound (Biolosion) in patients with advanced urothelial carcinoma. Guangzhou: US National Library of Medicine. https:\/\/clinicaltrials.gov\/study\/NCT06904573."},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_100041"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-021-03882-2"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2024.0024"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-018-0592-6"}],"container-title":["OncoImmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/2162402X.2025.2611458","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T08:55:57Z","timestamp":1768985757000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/2162402X.2025.2611458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/2162402X.2025.2611458"],"URL":"https:\/\/doi.org\/10.1080\/2162402x.2025.2611458","relation":{},"ISSN":["2162-402X"],"issn-type":[{"value":"2162-402X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=koni20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=koni20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-08-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-19","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2611458"}}